» Articles » PMID: 12100898

Upregulation of Chemokines in Bronchoalveolar Lavage Fluid As a Predictive Marker of Post-transplant Airway Obliteration

Overview
Publisher Elsevier
Date 2002 Jul 9
PMID 12100898
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The early stage of post-transplant obliterative bronchiolitis (OB) is characterized by an influx of inflammatory cells to the lung, among which neutrophils may play a role in key events. The potential for chemokines to induce leukocyte accumulation in the alveolar space was investigated. We assessed whether changes in the chemotactic expression profile could be used as sensitive markers of the onset of OB.

Methods: Serial bronchoalveolar lavage (BAL) fluids from 13 stable healthy recipients and 8 patients who developed bronchiolitis obliterans syndrome (BOS) were analyzed longitudinally for concentrations of interleukin-8 (IL-8), chemokines regulated-upon-activation and normal T-cell expressed and secreted (RANTES) and monocyte chemoattractant protein-1 (MCP-1), soluble intracellular adhesion molecule-1 (sICAM-1) and vascular cell adhesion molecule-1 (VCAM-1). These were assessed by enzyme-linked immunosorbent assay (ELISA).

Results: Significantly elevated percentages of BAL neutrophils and IL-8 levels were found at the pre-clinical stage of BOS, on average 151 +/- 164 days and 307 +/- 266 days, respectively, before diagnosis of BOS. There was also early upregulation of RANTES and MCP-1 in the BOS group (mean 253 +/- 323 and 152 +/- 80 days, respectively, before diagnosis of BOS). The level of MCP-1 was consistently higher than that of RANTES until airway obliteration. BAL sICAM-1 and sVCAM-1 levels were not statistically different between the groups.

Conclusions: These data support the belief that RANTES, IL-8 and MCP-1 play a crucial role in the pathogenesis of OB. The results show that relevant increased levels of such chemokines may predict BOS, and suggest that there is potential for some of these markers to be used as early and sensitive markers of the onset of BOS. Longitudinal monitoring of these chemokine signals may contribute to better management of patients at risk for developing OB, at a stage when remodeling can either be reversed or altered.

Citing Articles

Heterogeneous neutrophils in lung transplantation and proteolytic CXCL8 activation in COVID-19, influenza and lung transplant patient lungs.

Cambier S, Beretta F, Nooyens A, Metzemaekers M, Portner N, Kaes J Cell Mol Life Sci. 2024; 81(1):475.

PMID: 39625496 PMC: 11615237. DOI: 10.1007/s00018-024-05500-z.


Chronic Lung Allograft Dysfunction Is Associated with Increased Levels of Cell-Free Mitochondrial DNA in Bronchoalveolar Lavage Fluid of Lung Transplant Recipients.

Schneck E, Askevold I, Rath R, Hecker A, Reichert M, Guth S J Clin Med. 2022; 11(14).

PMID: 35887906 PMC: 9322792. DOI: 10.3390/jcm11144142.


Effector immune cells in chronic lung allograft dysfunction: A systematic review.

Bos S, Filby A, Vos R, Fisher A Immunology. 2022; 166(1):17-37.

PMID: 35137398 PMC: 9426626. DOI: 10.1111/imm.13458.


Clinical analysis of adenovirus postinfectious bronchiolitis obliterans and nonadenovirus postinfectious bronchiolitis obliterans in children.

Huang F, Ma Y, Wang F, Li Y Lung India. 2021; 38(2):117-121.

PMID: 33687003 PMC: 8098888. DOI: 10.4103/lungindia.lungindia_374_20.


Screening and identification of key regulatory connections and immune cell infiltration characteristics for lung transplant rejection using mucosal biopsies.

Xiu M, Liu Z, Tang J Int Immunopharmacol. 2020; 87:106827.

PMID: 32791489 PMC: 7417178. DOI: 10.1016/j.intimp.2020.106827.